These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 4200593)
1. Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A. Liu PV; Hsieh H J Infect Dis; 1973 Oct; 128(4):520-6. PubMed ID: 4200593 [No Abstract] [Full Text] [Related]
2. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection. Pollack M; Callahan LT; Taylor NS Infect Immun; 1976 Oct; 14(4):942-7. PubMed ID: 825470 [TBL] [Abstract][Full Text] [Related]
3. Further studies on the cholera toxin and antitoxin. Ungar J; Stanić M; Varallyay SJ; Chariatte N Prog Immunobiol Stand; 1970; 4():583-9. PubMed ID: 4099025 [No Abstract] [Full Text] [Related]
4. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa. Jones RJ Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304 [No Abstract] [Full Text] [Related]
5. External otitis: production of Pseudomonas aeruginosa antibodies. Carr CD; Sonnenwirth AC; Senturia BH Ann Otol Rhinol Laryngol; 1967 Jun; 76(2):393-408. PubMed ID: 4961505 [No Abstract] [Full Text] [Related]
6. Experimental immunization with attenuated mutants of Pseudomonas aeruginosa. Syeklocha D Can J Microbiol; 1973 May; 19(5):573-80. PubMed ID: 4196781 [No Abstract] [Full Text] [Related]
7. Pseudomonas aeruginosa exotoxin: purification by preparative polyacrylamide gel electrophoresis and the development of a highly specific antitoxin serum. Callahan LT Infect Immun; 1976 Jul; 14(1):55-61. PubMed ID: 820647 [TBL] [Abstract][Full Text] [Related]
12. Cholera antitoxin titrations: a comparative study of fat-cell, ileal-loop, and rabbit-skin assays. Curlin CT; Mosley WH; Greenough WB J Infect Dis; 1973 Mar; 127(3):294-8. PubMed ID: 4734668 [No Abstract] [Full Text] [Related]
13. Preparation and assay of horse anti-Pseudomonas serum and -globulin in mice. Laborde HF; De Fajardo CL Prog Immunobiol Stand; 1971; 5():419-24. PubMed ID: 4633969 [No Abstract] [Full Text] [Related]
14. [Epidemiological studies of pseudomonas hospitalism (author's transl)]. May W; Burchardi H; Killian W MMW Munch Med Wochenschr; 1974 Jan; 116(3):97-104. PubMed ID: 4205625 [No Abstract] [Full Text] [Related]
15. [Extraction and characteristics of agglutinating sera to the O-antigens of Pseudomonas aeruginosa]. Smirnova NE; Akatova NS Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):119-22. PubMed ID: 804787 [TBL] [Abstract][Full Text] [Related]
16. Serological typing of Pseudomonas aeruginosa and several points to be considered. Homma JY Jpn J Exp Med; 1974 Feb; 44(1):1-12. PubMed ID: 4207740 [No Abstract] [Full Text] [Related]
17. [Antibodies against Pseudomonas aeruginosa toxin in preparations of normal human immunoglobulin]. Ianishevskaia MN; Kuz'mina NS; Kutimova LR; Lents MN; Minakova LV Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):100-3. PubMed ID: 6412489 [TBL] [Abstract][Full Text] [Related]
18. Neutralization of murine typhus toxin by serum of normal human beings and monkeys. Bell EJ; Lackman DB; Ormsbee RA; Peacock M Am J Trop Med Hyg; 1969 Jul; 18(4):559-67. PubMed ID: 4307579 [No Abstract] [Full Text] [Related]
20. Specific impairment of host defense for pseudomonas infection in mice by a burn toxin derived from thermally altered human skin. Müller W; Allgöwer M; Städtler K; Burkhart F; Schoenenberger GA Res Exp Med (Berl); 1974 Jan; 162(2):153-60. PubMed ID: 4205633 [No Abstract] [Full Text] [Related] [Next] [New Search]